A study of Avacopan in atypical hemolytic uremic syndrome (aHUS)
Phase of Trial: Phase III
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Avacopan (Primary)
- Indications Haemolytic uraemic syndrome
- Focus Therapeutic Use
- 20 Jan 2017 New trial record
- 09 Jan 2017 According to a ChemoCentryx media release, if successful, the study could support registration of the drug.
- 09 Jan 2017 According to a ChemoCentryx media release, this study is expected to initiate in 2017.